Länder Analysen: Schweiz

20.01.22 Novartis Underweight JP Morgan Chase & Co.
19.01.22 Givaudan Underweight Barclays Capital
17.01.22 UBS Underweight JP Morgan Chase & Co.
12.01.22 Novartis Underweight JP Morgan Chase & Co.
06.01.22 UBS Underweight JP Morgan Chase & Co.
05.01.22 Nestlé Underperform Jefferies & Company Inc.
04.01.22 Novartis Underweight JP Morgan Chase & Co.
20.12.21 Novartis Underweight JP Morgan Chase & Co.
17.12.21 Novartis Sell Deutsche Bank AG
16.12.21 Novartis Underweight JP Morgan Chase & Co.
10.12.21 DocMorris Sell UBS AG
06.12.21 Novartis Sell Deutsche Bank AG
03.12.21 Novartis Underweight JP Morgan Chase & Co.
01.12.21 DocMorris Sell UBS AG
18.11.21 Givaudan Underperform Bernstein Research
16.11.21 UBS Underweight JP Morgan Chase & Co.
04.11.21 Novartis Underweight JP Morgan Chase & Co.
02.11.21 Clariant Underweight JP Morgan Chase & Co.
29.10.21 Swiss Re Sell UBS AG
28.10.21 Clariant Underweight JP Morgan Chase & Co.
27.10.21 Novartis Underweight Barclays Capital
27.10.21 UBS Underweight Barclays Capital
27.10.21 Novartis Sell Deutsche Bank AG
27.10.21 Novartis Underweight JP Morgan Chase & Co.
26.10.21 Novartis Underweight JP Morgan Chase & Co.
26.10.21 Novartis Sell Deutsche Bank AG
26.10.21 UBS Underweight Barclays Capital
25.10.21 Novartis Underweight JP Morgan Chase & Co.
25.10.21 DocMorris Sell UBS AG
22.10.21 DocMorris Sell UBS AG
19.10.21 Givaudan Underweight Barclays Capital
14.10.21 Swiss Re Sell UBS AG
14.10.21 Givaudan Underperform Jefferies & Company Inc.
12.10.21 UBS Underweight Barclays Capital
12.10.21 Givaudan Underperform Bernstein Research
05.10.21 Novartis Underweight JP Morgan Chase & Co.
05.10.21 Swiss Re Sell UBS AG
01.10.21 DocMorris Sell UBS AG
20.09.21 Novartis Sell Deutsche Bank AG
17.09.21 Swiss Re Sell UBS AG
14.09.21 Novartis Underweight JP Morgan Chase & Co.
31.08.21 Swiss Re Sell UBS AG
27.08.21 Clariant Underweight JP Morgan Chase & Co.
25.08.21 DocMorris Sell UBS AG
20.08.21 Givaudan Underperform Bernstein Research
19.08.21 DocMorris Sell UBS AG
17.08.21 Swiss Re Sell UBS AG
10.08.21 Givaudan Underweight Barclays Capital
02.08.21 Swiss Re Sell UBS AG
29.07.21 Clariant Underweight JP Morgan Chase & Co.